Haemophilus influenzae type b and Meningococcal Conjugate Vaccine

The Haemophilus influenzae type b (Hib) and meningococcal conjugate vaccine is a combination vaccine that protects against two serious bacterial infections: Haemophilus influenzae type b and Neisseria meningitidis (meningococcus).

Haemophilus influenzae type b (Hib)

Haemophilus influenzae type b is a bacterium that can cause severe infections, including:

  • Meningitis: inflammation of the membranes surrounding the brain and spinal cord
  • Epiglottitis: inflammation of the epiglottis, which can lead to respiratory obstruction
  • Pneumonia: infection of the lungs
  • Septicemia: blood infection
  • Osteomyelitis: bone infection
  • Arthritis: joint infection

Neisseria meningitidis (Meningococcus)

Neisseria meningitidis is a bacterium that can cause severe infections, including:

  • Meningitis: inflammation of the membranes surrounding the brain and spinal cord
  • Septicemia: blood infection
  • Pneumonia: infection of the lungs

Vaccine Components

The Hib and meningococcal conjugate vaccine typically contains:

  • Polyribosyl ribitol phosphate (PRP) from Haemophilus influenzae type b, which is conjugated to a carrier protein such as tetanus toxoid or diphtheria toxoid
  • Meningococcal polysaccharides from Neisseria meningitidis serogroups A, C, W, and Y, which are conjugated to a carrier protein such as diphtheria toxoid or CRM197 (a non-toxic mutant of diphtheria toxin)

Administration and Schedule

The Hib and meningococcal conjugate vaccine is typically administered in a series of doses, with the first dose given at 2 months of age and subsequent doses given at 4, 6, and 12-15 months of age. A booster dose may be given at 4-6 years of age.

Contraindications and Precautions

The Hib and meningococcal conjugate vaccine is contraindicated in individuals with a history of severe allergic reaction to any component of the vaccine or to previous doses of the vaccine. Precautions should be taken when administering the vaccine to individuals with a history of Guillain-Barré Syndrome or with immunodeficiency.

Side Effects

Common side effects of the Hib and meningococcal conjugate vaccine include:

  • Pain, redness, or swelling at the injection site
  • Fever
  • Irritability
  • Drowsiness
  • Loss of appetite

Efficacy and Effectiveness

The Hib and meningococcal conjugate vaccine has been shown to be highly effective in preventing invasive Haemophilus influenzae type b and Neisseria meningitidis infections. The vaccine has also been shown to reduce the risk of disease transmission and to provide herd immunity.

Article last updated on: 6th June 2025.
If you have any feedback, please get in touch.

Not just another AI Scribe.
Differentials. Guidance. Transcriptions. Notes.


Available for iOS, macOS and Android.

Medical Disclaimer

The information provided is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site. We we do not guarantee, and assume no legal liability or responsibility for the accuracy, currency, or completeness of the information provided.